PH vaccine experts studies ‘Sputnik V’ documents ahead of potential trials

Share on facebook
Share on twitter
Share on email
Spread the love
FILE PHOTO: A small bottle labeled with a “Vaccine” sticker is held near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic

Philippine’s research panel for vaccine is now looking into Russia’s report on its registered coronavirus vaccine “Sputnik V” to ascertain it is safe for Filipino’s clinical testing.

Department of Science and Technology-Philippine Council for Health Research and Development, Executive Director Dr. Jaime Montoya confirmed that they have received detailed reports on the Phase 1 and 2 of said Russian-produced vaccine.

A comprehensive review of these documents will be conducted to ensure safety and efficacy of the vaccine before the Philippines can move a step closer to holding the Phase 3 in the country.

“They will be releasing their evaluation hopefully by next week,” Montoya said in a text message.

Health spokesperson Maria Rosario Vergeire added the Philippines has yet to finalize several legal documents for the trial, such as the confidentiality disclosure agreements.

The Food and Drug Administration must approve the conduct of trials before it can be started in the Philippines.

Once it is approved, around 1,000 healthy participants from the Philippines will participate the Phase 3. This crucial phase is required before the FDA reviews the vaccine for mass vaccination.

LATEST NEWS

TRENDING NEWS